These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Potential cost savings using GnRH agonists as preoperative therapy for uterine leiomyomas. Saltiel E Formulary; 1995 Sep; 30(9):532-4, 542. PubMed ID: 10161243 [TBL] [Abstract][Full Text] [Related]
3. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids. Lethaby A; Vollenhoven B; Sowter M Cochrane Database Syst Rev; 2000; (2):CD000547. PubMed ID: 10796723 [TBL] [Abstract][Full Text] [Related]
4. GnRH agonists before surgery for uterine leiomyomas. A review. Crosignani PG; Vercellini P; Meschìa M; Oldani S; Bramante T J Reprod Med; 1996 Jun; 41(6):415-21. PubMed ID: 8799917 [TBL] [Abstract][Full Text] [Related]
5. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids. Lethaby A; Vollenhoven B; Sowter M Cochrane Database Syst Rev; 2001; (2):CD000547. PubMed ID: 11405968 [TBL] [Abstract][Full Text] [Related]
6. Use of a gonadotropin-releasing hormone agonist to manage perimenopausal women with symptomatic uterine myomas. Wang PH; Lee WL; Cheng MH; Yen MS; Chao KC; Chao HT Taiwan J Obstet Gynecol; 2009 Jun; 48(2):133-7. PubMed ID: 19574174 [TBL] [Abstract][Full Text] [Related]
8. [A comparative efficacy study of the preoperative use of GnRH agonists in women with uterine fibromyomas]. Nikolov A; Karag'ozov I Akush Ginekol (Sofiia); 1999; 38(4):38-42. PubMed ID: 10726353 [TBL] [Abstract][Full Text] [Related]
9. Leiomyoma pseudocapsule after pre-surgical treatment with gonadotropin-releasing hormone agonists: relationship between clinical features and immunohistochemical changes. De Falco M; Staibano S; Mascolo M; Mignogna C; Improda L; Ciociola F; Carbone IF; Di Lieto A Eur J Obstet Gynecol Reprod Biol; 2009 May; 144(1):44-7. PubMed ID: 19297072 [TBL] [Abstract][Full Text] [Related]